Skip to content

72 hour moisturization Activity of SkinQ moisture Balm on Dry skin

A Clinical Study to evaluate the 72 hour moisturization potential of SkinQ moisture Balm on Dry skin - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101716
Enrollment
32
Registered
2026-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: SkinQ Moisture Balm: Test Product: SkinQ Moisture Balm, Route of administration: Topical, Frequency :2-3gm cream over one hand, Duration: 72 hours Control Intervention1: N

Sponsors

Health Q Lifesciences Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Male or Female 18 to 45 2) Subjects willing to give written informed consent. 3) Volunteers with dry skin 4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Chronic illness which may influence the outcome of the study 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period.

Design outcomes

Primary

MeasureTime frame
Change in hydration Chnage in TEWL Timepoint: T0min, T+30 mins, T+24 hours, T +48 hours, T + 72 hours

Secondary

MeasureTime frame
chnage in SebumTimepoint: T0min, T1hr

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026